2023
DOI: 10.1002/sstr.202300062
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in Functional Nanoparticle Assemblies

Abstract: Assemblies of colloidal nanoparticles (NPs) into various functional superstructures, such as ordered or nonordered, microscopic or macroscopic, and templated or self‐supported, have recently attracted a lot of research interest. The continuous development of colloidal nanoparticle synthesis enables a fine‐tuning of the structure and properties of such functional superstructures leading to numerous new applications. Herein, it is aimed to summarize a variety of assemblies based on ordered self‐assembled NPs, e.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 205 publications
0
1
0
Order By: Relevance
“…[ 159 ] These functional moieties, including enzymes, antibodies, aptamers, small molecules, and other targeting molecules, can be attached to drug carriers via various interactions, recognizing receptors expressed in cancer cells or the tumor microenvironment. [ 160–162 ] In recent years, the emergence of cell‐mediated drug delivery systems as promising strategies has occurred. [ 163 ] By leveraging unique cell properties such as extended blood circulation, abundant surface ligands that potentially enable specific hitchhiking, targeted tumor cell interactions, and adaptable morphology that navigates biological barriers, these systems optimize therapeutic outcomes while minimizing side effects.…”
Section: Triggering Immunogenic Cell Death With Aie Therapeutic Agentsmentioning
confidence: 99%
“…[ 159 ] These functional moieties, including enzymes, antibodies, aptamers, small molecules, and other targeting molecules, can be attached to drug carriers via various interactions, recognizing receptors expressed in cancer cells or the tumor microenvironment. [ 160–162 ] In recent years, the emergence of cell‐mediated drug delivery systems as promising strategies has occurred. [ 163 ] By leveraging unique cell properties such as extended blood circulation, abundant surface ligands that potentially enable specific hitchhiking, targeted tumor cell interactions, and adaptable morphology that navigates biological barriers, these systems optimize therapeutic outcomes while minimizing side effects.…”
Section: Triggering Immunogenic Cell Death With Aie Therapeutic Agentsmentioning
confidence: 99%